J M Graf - JoVE Visualize

Showing results (21-30 of 47) with videos related to

Pageof 5

Sort By:

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2003

Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in GermanyTim Schwermann, Wolfgang Greiner, J M Graf v d Schulenburg

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 4, 2005

Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in GermanyWerner Kulp, J-M Graf von der Schulenburg, Wolfgang Greiner

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|December 29, 2000

[Using the excimer laser in refractive eye surgery. Results of a survey of German ophthalmologists]W Kulp, W Greiner, J M Graf von der Schulenburg

Tobacco Induced Diseases|August 27, 2016

Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysisI Aumann, L Tedja, J M Graf von der Schulenburg

Pneumologie (Stuttgart, Germany)|August 4, 1999

[Quality of life of adult asthma patients]W Greiner, J M Graf von der Schulenberg, K C Bergmann

Zentralblatt Fur Chirurgie|January 1, 1993

[Risk factors of perioperative morbidity and mortality in colorectal cancer with special reference to tumor stage, site and age]H Menke, J M Graf, A Heintz, et al.

Medizinische Klinik (Munich, Germany : 1983)|October 15, 1996

[Cost of asthma therapy in relation to severity. An empirical study]J M Graf von der Schulenburg, W Greiner, S Molitor, et al.

Deutsche Medizinische Wochenschrift (1946)|February 11, 2010

[Costs of ulcerative colitis within the German Statutory Health Insurance]A Prenzler, B Bokemeyer, T Mittendorf, et al.

Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 27, 2016

[Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review]I Aumann, K Rozanski, K Damm, et al.

Medizinische Klinik (Munich, Germany : 1983)|January 31, 1998

[Economic aspects in treatment of cystic fibrosis with chronic pulmonary pseudomonas infection. Ambulatory intravenous therapy in comparison with inpatient treatment]J M Graf von der Schulenburg, W Greiner, U Klettke, et al.

Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:

Pageof 5

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2003

Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in GermanyTim Schwermann, Wolfgang Greiner, J M Graf v d Schulenburg

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 4, 2005

Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in GermanyWerner Kulp, J-M Graf von der Schulenburg, Wolfgang Greiner

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|December 29, 2000

[Using the excimer laser in refractive eye surgery. Results of a survey of German ophthalmologists]W Kulp, W Greiner, J M Graf von der Schulenburg

Tobacco Induced Diseases|August 27, 2016

Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysisI Aumann, L Tedja, J M Graf von der Schulenburg

Pneumologie (Stuttgart, Germany)|August 4, 1999

[Quality of life of adult asthma patients]W Greiner, J M Graf von der Schulenberg, K C Bergmann

Zentralblatt Fur Chirurgie|January 1, 1993

[Risk factors of perioperative morbidity and mortality in colorectal cancer with special reference to tumor stage, site and age]H Menke, J M Graf, A Heintz, et al.

Medizinische Klinik (Munich, Germany : 1983)|October 15, 1996

[Cost of asthma therapy in relation to severity. An empirical study]J M Graf von der Schulenburg, W Greiner, S Molitor, et al.

Deutsche Medizinische Wochenschrift (1946)|February 11, 2010

[Costs of ulcerative colitis within the German Statutory Health Insurance]A Prenzler, B Bokemeyer, T Mittendorf, et al.

Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 27, 2016

[Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review]I Aumann, K Rozanski, K Damm, et al.

Medizinische Klinik (Munich, Germany : 1983)|January 31, 1998

[Economic aspects in treatment of cystic fibrosis with chronic pulmonary pseudomonas infection. Ambulatory intravenous therapy in comparison with inpatient treatment]J M Graf von der Schulenburg, W Greiner, U Klettke, et al.

Pageof 5